REVEAL Lite 2 risk assessment prognostic of long-term outcomes in pulmonary hypertension

The REVEAL Lite 2 risk assessment tool is prognostic of long-term outcomes in patients with pulmonary arterial hypertension and also detected response to treatment, a presenter said at the CHEST Annual Meeting.“Risk assessment, as we know, is key for optimal management of patients with pulmonary arterial hypertension,” Raymond L. Benza, MD, cardiologist in the division of

Read the full article here

Related Articles